Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Sonnet BioTherapeutics Shares Are Falling Over 30%

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 36.9% to $1.72 during Monday's trading session after the company announced a 1-for-14 reverse stock split. What Else?
byHenry Khederian
September 19, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares are trading lower by 36.9% to $1.72 during Monday’s trading session after the company announced a 1-for-14 reverse stock split.

What Else?

Sonnet BioTherapeutics says the reverse stock split is intended to increase the per share trading price of Sonnet’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)).

This split is effective for trading purposes as of Monday’s session.

See Also: So Is Dogecoin Heading Back to 5 Cents Or Making A Run To 10 Cents? Survey Says…

According to data from Benzinga Pro, Sonnet BioTherapeutics has a 52-week high of $2.29 and a 52-week low of $0.19.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Over $4M Bet On This Financial Services Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin
May 10, 8:52 AM
The Dow Jones closed lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CRKR